Zai Lab Limited Is A Global Biopharmaceutical Company Based In Shanghaichinawith Significant Operations In The U Sfounded In 2013 Or 2014It Is Listed On Nasdaq And Hkexthe Company Focuses On Developing And Commercializing Therapies In Oncologyneuroscienceautoimmune Disordersand Infectious Diseaseszai Lab Has A Strong Pipeline With Over 15 Clinical Stage Assetsincluding Five Approved Therapies In China Led By Chairperson And Ceo Drsamantha Duzai Lab Employs Between 600 And 2 100 People Across Seven Global Locationsin 2023The Company Reported A Revenue Of $318 4 Million And Invested $444 2 Million In Research And Developmentzai Lab Has Established Strategic Partnerships With Major Pharmaceutical Companies Like Regeneron Pharmaceuticals And Novartis To Enhance Its Drug Development Effortsthe Company Is Known For Its Expertise In Fast Track Regulatory Pathways In China And Its Integrated Capabilities That Encompass Discoverydevelopmentmanufacturingand Commercialization
No conferences found for this company.
| Company Name | Zai Lab Pty Ltd |
| Country |
South Africa
|
| Address | N/A |
| Telephone | N/A |
| N/A |
